Latin America and the Caribbean: Market for Medicaments Of Penicillins, Streptomycins Or Derivatives Thereof 2024

Market Size for Medicaments Of Penicillins, Streptomycins Or Derivatives Thereof in Latin America and the Caribbean

The Latin American penicillins or streptomycins medicaments market contracted slightly to $X in 2022, remaining stable against the previous year. The total consumption indicated a strong increase from 2012 to 2022: its value increased at an average annual rate of +5.0% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, consumption decreased by -8.2% against 2018 indices. Over the period under review, the market reached the peak level at $X in 2018; however, from 2019 to 2022, consumption failed to regain momentum.

Production of Medicaments Of Penicillins, Streptomycins Or Derivatives Thereof in Latin America and the Caribbean

In value terms, penicillins or streptomycins medicaments production reduced to $X in 2022 estimated in export price. The total production indicated a perceptible increase from 2012 to 2022: its value increased at an average annual rate of +4.9% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, production decreased by +0.5% against 2020 indices. The most prominent rate of growth was recorded in 2013 when the production volume increased by 27%. Over the period under review, production reached the peak level at $X in 2018; however, from 2019 to 2022, production failed to regain momentum.

Exports of Medicaments Of Penicillins, Streptomycins Or Derivatives Thereof

Exports in Latin America and the Caribbean

After five years of decline, shipments abroad of medicaments of penicillins, streptomycins or derivatives thereof increased by 41% to X tons in 2022. Over the period under review, exports, however, saw a abrupt downturn. Over the period under review, the exports attained the maximum at X tons in 2012; however, from 2013 to 2022, the exports stood at a somewhat lower figure.

In value terms, penicillins or streptomycins medicaments exports soared to $X in 2022. In general, exports, however, continue to indicate a deep setback. Over the period under review, the exports hit record highs at $X in 2013; however, from 2014 to 2022, the exports failed to regain momentum.

Exports by Country

The biggest shipments were from Colombia (X tons), Argentina (X tons), Brazil (X tons) and Guatemala (X tons), together accounting for 64% of total export. It was distantly followed by Panama (X tons), Chile (X tons) and Mexico (X tons), together achieving a 20% share of total exports.

From 2012 to 2022, the most notable rate of growth in terms of shipments, amongst the main exporting countries, was attained by Brazil (with a CAGR of +17.6%), while the other leaders experienced a decline in the exports figures.

In value terms, the largest penicillins or streptomycins medicaments supplying countries in Latin America and the Caribbean were Argentina ($X), Colombia ($X) and Guatemala ($X), with a combined 50% share of total exports. Panama, Brazil, Chile and Mexico lagged somewhat behind, together accounting for a further 35%.

Among the main exporting countries, Brazil, with a CAGR of +12.1%, recorded the highest rates of growth with regard to the value of exports, over the period under review, while shipments for the other leaders experienced a decline in the exports figures.

Export Prices by Country

The export price in Latin America and the Caribbean stood at $X per ton in 2022, remaining relatively unchanged against the previous year. In general, the export price, however, continues to indicate a perceptible curtailment. The pace of growth appeared the most rapid in 2019 an increase of 15%. The level of export peaked at $X per ton in 2013; however, from 2014 to 2022, the export prices failed to regain momentum.

Prices varied noticeably by country of origin: amid the top suppliers, the country with the highest price was Panama ($X per ton), while Mexico ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Argentina (+0.7%), while the other leaders experienced mixed trends in the export price figures.

Imports of Medicaments Of Penicillins, Streptomycins Or Derivatives Thereof

Imports in Latin America and the Caribbean

In 2022, purchases abroad of medicaments of penicillins, streptomycins or derivatives thereof was finally on the rise to reach X tons for the first time since 2017, thus ending a four-year declining trend. Overall, imports, however, recorded a relatively flat trend pattern. The growth pace was the most rapid in 2015 when imports increased by 17%. The volume of import peaked at X tons in 2017; however, from 2018 to 2022, imports failed to regain momentum.

In value terms, penicillins or streptomycins medicaments imports expanded sharply to $X in 2022. Over the period under review, imports, however, continue to indicate a slight curtailment. The growth pace was the most rapid in 2017 when imports increased by 13% against the previous year. As a result, imports reached the peak of $X. From 2018 to 2022, the growth of imports failed to regain momentum.

Imports by Country

In 2022, Brazil (X tons), distantly followed by Peru (X tons), Chile (X tons), Ecuador (X tons), Colombia (X tons), Honduras (X tons) and Bolivia (X tons) represented the largest importers of medicaments of penicillins, streptomycins or derivatives thereof, together making up 72% of total imports. Panama (X tons), Guatemala (X tons), El Salvador (X tons), Cuba (X tons), Nicaragua (X tons) and Venezuela (X tons) followed a long way behind the leaders.

Imports into Brazil increased at an average annual rate of +1.6% from 2012 to 2022. At the same time, Bolivia (+7.5%), Panama (+6.9%), Guatemala (+6.2%), Colombia (+5.9%), Peru (+5.1%), Chile (+3.6%) and Ecuador (+2.7%) displayed positive paces of growth. Moreover, Bolivia emerged as the fastest-growing importer imported in Latin America and the Caribbean, with a CAGR of +7.5% from 2012-2022. Nicaragua, Cuba and Honduras experienced a relatively flat trend pattern. By contrast, El Salvador (-2.3%) and Venezuela (-15.1%) illustrated a downward trend over the same period. While the share of Brazil (+4.5 p.p.), Peru (+4.2 p.p.), Bolivia (+3.5 p.p.), Colombia (+3.3 p.p.), Chile (+2.9 p.p.), Ecuador (+2.3 p.p.), Panama (+1.9 p.p.) and Guatemala (+1.5 p.p.) increased significantly in terms of the total imports from 2012-2022, the share of Venezuela (-9 p.p.) displayed negative dynamics. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, Brazil ($X) constitutes the largest market for imported medicaments of penicillins, streptomycins or derivatives thereof in Latin America and the Caribbean, comprising 31% of total imports. The second position in the ranking was taken by Ecuador ($X), with a 10% share of total imports. It was followed by Colombia, with a 9.3% share.

From 2012 to 2022, the average annual growth rate of value in Brazil stood at +2.8%. In the other countries, the average annual rates were as follows: Ecuador (+4.6% per year) and Colombia (+0.1% per year).

Import Prices by Country

The import price in Latin America and the Caribbean stood at $X per ton in 2022, with a decrease of -1.9% against the previous year. In general, the import price showed a relatively flat trend pattern. The most prominent rate of growth was recorded in 2019 an increase of 14%. Over the period under review, import prices attained the maximum at $X per ton in 2013; however, from 2014 to 2022, import prices remained at a lower figure.

Prices varied noticeably by country of destination: amid the top importers, the country with the highest price was Nicaragua ($X per ton), while Cuba ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by El Salvador (+6.7%), while the other leaders experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :